Table 2.
Expression of genes in PMNL incubated with 0 (control) or 0.05% tee trea oil (TTO) in vitro
| Symbol | Treatment1 | SEM | P-value | |
|---|---|---|---|---|
| Control | TTO | |||
| IL-1β | 1.43 | 0.86 | 0.23 | 0.38 |
| IL-6 | 1.19 | 1.38 | 0.22 | 0.81 |
| IL-8 | 1.21 | 1.25 | 0.18 | 0.93 |
| IL-10 | 1.24a | 0.16b | 0.18 | 0.001 |
| TNF-α | 1.14a | 0.42b | 0.46 | 0.02 |
| TLR-2 | 1.49 | 0.41 | 0.47 | 0.05 |
| TLR-4 | 1.25 | 0.94 | 0.13 | 0.49 |
| L-seletin | 1.07 | 1.13 | 0.11 | 0.88 |
| IRAKI | 1.05 | 0.83 | 0.12 | 0.24 |
| NFKBIA | 1.05a | 0.52b | 0.13 | 0.02 |
| TRAF-6 | 1.04 | 0.93 | 0.09 | 0.51 |
| Lysozyme | 1.30 | 0.74 | 0.21 | 0.23 |
| SOD2 | 1.16 | 0.67 | 0.20 | 0.14 |
a, b Means in the same row with different superscripts differ significantly for treatment effect
1PMNL from six mid-lactating Holstein cows were incubated in DMEM/F12 medium in the absence of TTO (control group) or in the presence of 0.05% TTO (n = 6)